MyMD Pharmaceuticals, Inc. - Current Ratio

The Current Ratio as of July 2026 (TTM) for MyMD Pharmaceuticals, Inc. (MYMD) is 3.71

According to MyMD Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.71. This represents a change of 58.99% compared to the average of 2.34 of the last 4 quarters.

MyMD Pharmaceuticals, Inc. (MYMD) Historical Current Ratio (quarterly & annually)

How has MYMD Current Ratio performed in the past?

The mean historical Current Ratio of MyMD Pharmaceuticals, Inc. over the last ten years is 3.29. The current 3.71 Current Ratio has changed 11.18% with respect to the historical average. Over the past ten years (40 quarters), MYMD's Current Ratio was at its highest in in the March 2026 quarter at 3.71. The Current Ratio was at its lowest in in the March 2024 quarter at 0.62.

MyMD Pharmaceuticals, Inc. (MYMD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of MyMD Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MyMD Pharmaceuticals, Inc. (MYMD) Average Current Ratio

How has MYMD Current Ratio performed in the past?

The current Current Ratio of MyMD Pharmaceuticals, Inc. (MYMD) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

MyMD Pharmaceuticals, Inc. (MYMD) Current Ratio vs. Peers

How is MYMD’s Current Ratio compared to its peers?

MyMD Pharmaceuticals, Inc.’s Current Ratio is greater than Gamida Cell Ltd. (2.16), greater than Aptose Biosciences Inc. (0.55), less than Hillstream BioPharma, Inc. (37.75), greater than Nabriva Therapeutics plc (1.13), greater than VivoSim Labs, Inc. (2.38), greater than Altamira Therapeutics Ltd. (1.32), greater than Gritstone bio, Inc. (3.20), greater than Onconetix, Inc. (1.41), greater than Unity Biotechnology, Inc. (2.62), less than Neuphoria Therapeutics Inc. (14.31),

Build a custom stock screener for MyMD Pharmaceuticals, Inc. (MYMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MyMD Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MyMD Pharmaceuticals, Inc. (MYMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MyMD Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.